Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells
© 2022. The Author(s)..
Overcoming resistance to alkylating agents has important clinical significance in glioma. Cyanidin-3-O-glucoside (C3G) has a tumor-suppressive effect on tumor cells. However, whether it plays a role in temozolomide resistance in glioma is still unclear. We constructed a TMZ-resistant LN-18/TR glioma cell line, observed the effect of C3G on TMZ resistance in this cell line, and explored the role of miR-214-5p in chemoresistance. Results showed that β-catenin and MGMT were significantly upregulated in LN-18/TR cells. C3G upregulated miR-214-5p and enhanced the cytotoxic effect of temozolomide on LN-18/TR cells. Contrarily, C3G downregulated β-catenin and MGMT. Moreover, the miR-214-5p mimic downregulated β-catenin and MGMT in LN-18/TR cells, whereas the miR-214-5p inhibitor had the opposite effect; the miR-214-5p inhibitor significantly blocked the C3G-induced downregulation of β-catenin and MGMT. C3G or the miR-214-5p mimic enhanced temozolomide-induced apoptosis in LN-18/TR cells, whereas the miR-214-5p inhibitor blocked this effect. Furthermore, C3G or miR-214-5p agomir combined with TMZ significantly inhibited the growth of LN-18/TR tumors. Collectively, our research discovered the potential signaling mechanism associated with C3G-mediated suppression of TMZ resistance in LN-18/TR cells through miR-214-5p, which can facilitate the treatment of MGMT-induced resistance in glioma cells.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Scientific reports - 12(2022), 1 vom: 11. Mai, Seite 7773 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhou, Yuan [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 17.05.2022 Date Revised 16.07.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41598-022-11757-w |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM340738308 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM340738308 | ||
003 | DE-627 | ||
005 | 20231226204628.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41598-022-11757-w |2 doi | |
028 | 5 | 2 | |a pubmed24n1135.xml |
035 | |a (DE-627)NLM340738308 | ||
035 | |a (NLM)35545654 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhou, Yuan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cyanidin-3-O-glucoside inhibits the β-catenin/MGMT pathway by upregulating miR-214-5p to reverse chemotherapy resistance in glioma cells |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.05.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s). | ||
520 | |a Overcoming resistance to alkylating agents has important clinical significance in glioma. Cyanidin-3-O-glucoside (C3G) has a tumor-suppressive effect on tumor cells. However, whether it plays a role in temozolomide resistance in glioma is still unclear. We constructed a TMZ-resistant LN-18/TR glioma cell line, observed the effect of C3G on TMZ resistance in this cell line, and explored the role of miR-214-5p in chemoresistance. Results showed that β-catenin and MGMT were significantly upregulated in LN-18/TR cells. C3G upregulated miR-214-5p and enhanced the cytotoxic effect of temozolomide on LN-18/TR cells. Contrarily, C3G downregulated β-catenin and MGMT. Moreover, the miR-214-5p mimic downregulated β-catenin and MGMT in LN-18/TR cells, whereas the miR-214-5p inhibitor had the opposite effect; the miR-214-5p inhibitor significantly blocked the C3G-induced downregulation of β-catenin and MGMT. C3G or the miR-214-5p mimic enhanced temozolomide-induced apoptosis in LN-18/TR cells, whereas the miR-214-5p inhibitor blocked this effect. Furthermore, C3G or miR-214-5p agomir combined with TMZ significantly inhibited the growth of LN-18/TR tumors. Collectively, our research discovered the potential signaling mechanism associated with C3G-mediated suppression of TMZ resistance in LN-18/TR cells through miR-214-5p, which can facilitate the treatment of MGMT-induced resistance in glioma cells | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Anthocyanins |2 NLM | |
650 | 7 | |a Antineoplastic Agents, Alkylating |2 NLM | |
650 | 7 | |a Glucosides |2 NLM | |
650 | 7 | |a MIRN214 microRNA, human |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
650 | 7 | |a Tumor Suppressor Proteins |2 NLM | |
650 | 7 | |a beta Catenin |2 NLM | |
650 | 7 | |a cyanidin |2 NLM | |
650 | 7 | |a 7732ZHU564 |2 NLM | |
650 | 7 | |a DNA Modification Methylases |2 NLM | |
650 | 7 | |a EC 2.1.1.- |2 NLM | |
650 | 7 | |a MGMT protein, human |2 NLM | |
650 | 7 | |a EC 2.1.1.63 |2 NLM | |
650 | 7 | |a DNA Repair Enzymes |2 NLM | |
650 | 7 | |a EC 6.5.1.- |2 NLM | |
650 | 7 | |a Temozolomide |2 NLM | |
650 | 7 | |a YF1K15M17Y |2 NLM | |
700 | 1 | |a Chen, Li |e verfasserin |4 aut | |
700 | 1 | |a Ding, Deping |e verfasserin |4 aut | |
700 | 1 | |a Li, Ziheng |e verfasserin |4 aut | |
700 | 1 | |a Cheng, Li |e verfasserin |4 aut | |
700 | 1 | |a You, Qiuyun |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Shunbo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Scientific reports |d 2011 |g 12(2022), 1 vom: 11. Mai, Seite 7773 |w (DE-627)NLM215703936 |x 2045-2322 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2022 |g number:1 |g day:11 |g month:05 |g pages:7773 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41598-022-11757-w |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 12 |j 2022 |e 1 |b 11 |c 05 |h 7773 |